Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
This was the stock's second consecutive day of losses.
The owner of one of the three largest pharmacy middlemen in the United States filed suit on Sept. 16 to quash an attempt by ...
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
UnitedHealth Group Inc. struck a tentative deal to settle a class action challenging the Wells Fargo & Co. target date funds ...
Zacks.com on MSN2d
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
We recently compiled a list of the 12 Best Forever Stocks To Buy Now. In this article, we are going to take a look at where ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback